Search


 
Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 41-50 of 84 (Search time: 0.002 seconds).
Item hits:
First PublishedTitleAuthor(s)Type
1-May-1994CO-CHROMATOGRAPHY OF A TAMOXIFEN EPOXIDE DEOXYGUANYLIC ACID ADDUCT WITH A MAJOR DNA ADDUCT FORMED IN THE LIVERS OF TAMOXIFEN-TREATED RATSPHILLIPS, DH; HEWER, A; WHITE, INH; FARMER, PBJournal Article
1-Dec-1998Gemcitabine - a major advance?Thomas, A; Steward, WPJournal Article
1-Nov-1999Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancerSalud, A; Porcel, JM; Raikundalia, B; Camplejohn, RS; Taub, NAJournal Article
1-Jan-2000Molecular methods for the detection of mutationsMonteiro, C; Marcelino, LA; Conde, AR; Saraiva, C; Giphart-Gassler, M; De Nooij-van Dalen AG; Van Buuren-van Seggelen V; Van der Keur M; May, CA; Cole, J; Lehmann, AR; Steinsgrimsdottir, H; Beare, D; Capulas, E; Armour, JALJournal Article
1-Oct-1998Processing/activation of caspases, -3 and -7 and -8 but not caspase-2, in the induction of apoptosis in B-chronic lymphocytic leukemia cellsKing, D; Pringle, JH; Hutchinson, M; Cohen, GMJournal Article
1-Jan-1999The role of chemotherapy in the treatment of adult soft tissue sarcomasO'Byrne, K; Steward, WPJournal Article
1-Sep-1999Phase I study of liposomal daunorubicin (Daunoxome) in the treatment of metastatic breast cancerThomas, A; Shields, F; Wells-Jordan, P; Lloyd, D; Hubbard, A; Steward, WP; O'Byrne, KJJournal Article
1-Sep-1999Matrix metalloproteinase expression in normal, inflammed and malignant mesothelial tissuesEdwards, JG; Walker, RA; McLaren, J; Waller, DA; Steward, WP; O'Byrne, KJJournal Article
1-May-2000The Scottish and Manchester randomised trial of neo-adjuvant chemotherapy for advanced cervical cancerSymonds, RP; Habeshaw, T; Reed, NS; Paul, J; Pyper, E; Yosef, H; Davis, J; Hunter, R; Davidson, SE; Stewart, A; Cowie, V; Sarkar, TJournal Article
1-Dec-2009Ofatumumab, a Novel CD20 Monoclonal Antibody, Is Active in Patients With Fludarabine- and Alemtuzumab-Refractory or Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia Irrespective of Prior RituximabWierda, W; Kipps, T; Mayer, J; Stilgenbauer, S; Williams, CD; Hellmann, A; Robak, T; Furman, RR; Hillmen, P; Trneny, M; Dyer, MJS; Padmanabhan, S; Piotrowska, M; Kozak, T; Chan, G; Davis, R; Losic, N; Wilms, J; Russell, C; Osterborg, AJournal Article